Your browser doesn't support javascript.
loading
Turning a corner on HIV neutralization?
Nunberg, J H; Follis, K E; Trahey, M; LaCasse, R A.
Affiliation
  • Nunberg JH; Montana Biotechnology Center, The University of Montana, Missoula, MT 59812, USA.
Microbes Infect ; 2(2): 213-21, 2000 Feb.
Article in En | MEDLINE | ID: mdl-10742693
ABSTRACT
HIV vaccine development has been hampered by the inability of conventional immunogens to elicit antibodies capable of neutralizing primary isolates of the virus. Recent studies using 'fusion-competent' immunogens that capture transitional intermediate structures of the functioning envelope protein suggest that this goal may now be achievable.
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Vaccines, Synthetic / HIV Infections / HIV / AIDS Vaccines Limits: Animals / Humans Language: En Journal: Microbes Infect Journal subject: ALERGIA E IMUNOLOGIA / MICROBIOLOGIA Year: 2000 Document type: Article Affiliation country:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Vaccines, Synthetic / HIV Infections / HIV / AIDS Vaccines Limits: Animals / Humans Language: En Journal: Microbes Infect Journal subject: ALERGIA E IMUNOLOGIA / MICROBIOLOGIA Year: 2000 Document type: Article Affiliation country: